News | Cardiac Rehabilitation

Depression has been known to be associated with poor cardiovascular outcomes. But if patients who are depressed attend cardiac rehabilitation after heart surgery, their risk of death is significantly reduced, according to a new study.

Home November 15, 2016
Home
News | Atrial Fibrillation

Atrial fibrillation patients who use warfarin to lower risk of stroke are at higher risk of developing dementia than patients who use warfarin for non-atrial fibrillation conditions, according to a new study from the Intermountain Medical Center Heart Institute.

Home November 15, 2016
Home
News | Stethoscopes

Computational Signal Detection (CSD) Laboratories LLC announced the publication of data in support of the clinical utility of its eMurmur computer-aided auscultation (CAA) platform for early and ongoing heart-health screening of children.

Home November 15, 2016
Home
Technology | Cardiac Resynchronization Therapy Devices (CRT)

Medtronic plc has received U.S. Food and Drug Administration (FDA) approval for the Claria MRI Quad Cardiac Resynchronization Therapy Defibrillator (CRT-D) SureScan device for patients with heart failure. The Claria MRI CRT-D is approved for scanning in both 1.5 and 3 Tesla (T) magnetic resonance imaging (MRI) machines, and features EffectivCRT, a new algorithm that automatically tailors the therapy to individual patients by adjusting pacing rates.

Home November 15, 2016
Home
News | PET-CT

Many people who experience chest pain but don’t have a heart attack breathe a big sigh of relief when a stress test comes back negative for blockages in their blood vessels. But a new study by cardiac researchers at the Intermountain Medical Center Heart Institute in Salt Lake City found they may not be off the hook after all.

Home November 15, 2016
Home
News | Antiplatelet and Anticoagulation Therapies

Two differing blood clot prevention medications are just as safe and effective for patients undergoing percutaneous coronary intervention (PCI), according to a new study.

Home November 14, 2016
Home
News

Atrial fibrillation patients with a prior history of stroke who undergo catheter ablation lower their long-term risk of a recurrent stroke by 50 percent, according to new research from the Intermountain Medical Center Heart Institute.

Home November 14, 2016
Home
Videos | Heart Valve Technology

William Abraham, M.D., FACC, discusses advances in heart failure device treatment technologies at the Transcatheter ...

Home November 14, 2016
Home
News | Computed Tomography (CT)

Siemens Healthineers announced that University of Iowa Stead Family Children’s Hospital in Iowa City is the first facility in the United States to install the company’s Somatom Drive computed tomography (CT) system. This new high-performance scanner joins the Somatom Force and Somatom Definition Flash in the dual source segment of the company’s CT portfolio.

Home November 11, 2016
Home
News | Flat Panel Displays

Barco recently announced that Nexxis, its IP-based OR imaging management platform, is now operating in over 1,000 operating rooms worldwide.

Home November 11, 2016
Home
News | Cardiovascular Business

Siemens announced it intends to further develop its healthcare business, Siemens Healthineers, and give it even greater flexibility in implementing its growth plans. To this end, the company is planning to publicly list its healthcare business.

Home November 11, 2016
Home
News | Heart Valve Technology

November 10, 2016 — A Henry Ford Hospital cardiologist is pioneering a promising new procedure to improve the success of ...

Home November 10, 2016
Home
Technology | Point of Care Testing

Siemens Healthineers announced U.S. Food and Drug Administration (FDA) 510(k) clearance for a hand-held portable coagulation analyzer. The Xprecia Stride Coagulation Analyzer delivers fast, reliable Prothrombin Time/International Normalized Ratio (PT/INR) testing for point-of-care monitoring and management of oral anticoagulation therapy with warfarin, a vitamin K antagonist.

Home November 10, 2016
Home
News | Heart Valve Technology

NeoChord Inc. announced the first use of its DS1000 System in the United States as it enrolled the first patient in the RECHORD Trial.

Home November 10, 2016
Home
News | Cath Lab

Current ACCF/AHA guidelines recommend fibrinolysis (FL) as the preferred reperfusion strategy for ST-segment elevation myocardial infarction (STEMI) patients with expected delays of > 120 minutes from first medical contact to percutaneous coronary intervention (PCI). The guidelines recommend this be followed by transfer to a PCI center with angiography/PCI within 3-24 hours. However, assessment of reperfusion prior to angiography may not be accurate based on clinical and electrocardiogram (ECG) criteria alone. Recent data suggested increased recurrent ischemic events within the first 24 hours. The aim of this study, which was conducted from 2003-2015, was to assess the safety of very early PCI (< 3 hours) following FL.

Home November 10, 2016
Home
Subscribe Now